[Polythymolepsy (combined use of thymoleptics) in cases of endogenous depression].
D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D003984:Dibenzazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007099:Imipramine / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000928:Antidepressive Agents; D003984:Dibenzazepines; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D000639:Amitriptyline; D013881:Thioridazine; D007099:Imipramine
Zur Indikation der Polythymolepsie (kombinierte Anwendung von Thymoleptika) bei endogener Depression.